Aducanumab: a new phase in therapeutic development for Alzheimer's disease? (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202114781
PubMed Identifier: 34338436
Publication URI: http://europepmc.org/abstract/MED/34338436
Type: Journal Article/Review
Volume: 13
Parent Publication: EMBO molecular medicine
Issue: 8
ISSN: 1757-4676